The Childhood Neurotherapeutics CoEE is currently recruiting three endowed chairs: a University of South Carolina (USC)/Greenville Hospital System Translational Clinical Research Chair, a USC Child and Adolescent Neurochemistry Chair and an MUSC Neurodevelopmental Disorders Chair.

Priority areas for research have been identified. The first is Neuroprotection: Preventing Brain Damage in Premature Infants. This is highly relevant to South Carolina, which has a high incidence of premature birth. Second is Cellular Engineering: Fixing Broken Brains in Developmental Disease, exploring the latent capacity of neural stem cells for repair. Finally, the CoEE will address Autism Spectrum Disorder, looking at whether therapeutics will serve to improve functional developmental outcomes in children with autism.